X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Wspolczesna Onkologia-Contemporary Oncology

期刊標題檢索 WSPOLCZESNA ONK 最新評論: A comment is a type of research article published in journals, typical... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Wspolczesna Onkologia-Contemporary Oncology]您好,您是該頁面的第 11010 位訪客。

期刊簡介
期刊名稱Wspolczesna Onkologia-Contemporary Oncology Wspolczesna Onkologia-Contemporary Oncology

(According to the latest JCR data, this journal is not indexed in the JCR.)
LetPub Score
3.4
50 ratings
Rate

Reputation
3.7

Influence
2.4

Speed
7.0

期刊簡稱WSPOLCZESNA ONKOL
ISSN1428-2526
h-index16
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.100.5320.731
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q2165 / 333
Category: Medicine
Subcategory: Oncology
Q3244 / 404

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Contemporary Oncology is a journal aimed at oncologists, oncological surgeons, hematologists, radiologists, pathologists, radiotherapists, palliative care specialists, psychologists, nutritionists, and representatives of any other professions, whose interests are related to cancer. Manuscripts devoted to basic research in the field of oncology are also welcomed.
官方網站http://www.termedia.pl/Journal/-3
在線稿件提交http://www.editorialsystem.com/wo/
開放訪問Yes
出版商Termedia Publishing House Ltd.
主題領域医学
出版國/地區POLAND
發行頻率月刊
創刊年1997
每年文章數39每年文章數趨勢
黃金OA百分比96.72%
OA Related Info
APC: Yes( EUR200; )
APC waiver:No
Other charges: No
Keywords: oncology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYESCIQ2151/322
索引 (SCI or SCIE)
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1428-2526%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Wspolczesna Onkologia-Contemporary Oncology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS332254
    CANCER RESEARCH312227
    BMC CANCER245946
    Asian Pacific Journal of Cancer Prevention221081
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198025
    INTERNATIONAL JOURNAL OF CANCER191835
    CLINICAL CANCER RESEARCH181686
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY177298
    ONCOLOGY REPORTS175213
    CA-A CANCER JOURNAL FOR CLINICIANS163685
  •  

    Wspolczesna Onkologia-Contemporary Oncology Wspolczesna Onkologia-Contemporary Oncology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Wspolczesna Onkologia-Contemporary Oncology] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:08:27 評論於
A comment is a type of research article published in journals, typically consisting of expert opinions or critiques on hot topics or new research findings within a particular field
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:05:33 評論於
A Protocol is a type of research article published in journals, typically consisting of reviews or critiques by experts in the field on certain hot topics or new research findings
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 22:39:26 評論於
What is Protocol?
(0) 讚! | 北国博达

作者: 破戒阳平


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 13:27:18 評論於
What is a comment?
(0) 讚! | 破戒阳平

作者: 風見浩岚


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-07-05 16:38:25 評論於
The publication has been suspended
(0) 讚! | 風見浩岚

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-10-19 10:02:37 評論於
I paid the layout fee in July, but have not received any response to my emails. Today I found out that the publication has ceased. What does this mean? Have I been scammed?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-08-06 16:19:49 評論於
I just received a submission in May and paid 150 euros, what does this suspension mean
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-13 23:27:56 評論於
How come the magazine stopped publication??!! Just got published and now it's done!!!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-06-19 12:52:15 評論於
Review speed: 6.0 | Submission acceptance rate: 75.0 Experience sharing: rejected by a journal with impact factor of 1, then submitted to this one. It took 3 months to be accepted after 3 rounds of revisions. Mainly added some references from their journal. It took another 6 months to pay the publication fee, which was only 150 euros, cheaper than many domestic journals. Recommended for those who want to publish in SCI journals and don't care about the impact factor
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-05-29 12:22:09 評論於
Meta-analysis was submitted on August 1, 2013, revised on May 5, 2014, and accepted on May 29, 2014
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-02-27 18:13:29 評論於
Review speed: 6.0 | Submission acceptance rate: 75.0
Experience sharing: After submitting for over half a year, I received a rejection from the editorial office because the magazine does not have a case report section. They recommended resubmitting as a letter instead. After resubmitting, I received an acceptance in less than two months
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-01-15 10:59:33 評論於
Review speed: 6.0 Experience sharing: Reviewing is even slower than in China, taking more than 6 months for a case report. Later they said they no longer accept case reports and asked me to revise it into a letter
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-11-24 14:21:58 評論於
Review Speed: 3.0 Experience Sharing: I wrote a review on tumor-related topic, submitted on September 11, 2013, and received a reply on November 20, 2013 asking for minor revisions, which included adding a pathway diagram. I received the email on November 22, and completed the diagram that same evening to resubmit. The next morning, I was informed that the submission was accepted. The review process took over 2 months, with only 1 round of revisions, but the acceptance speed was quite fast
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-11-07 22:14:47 評論於
Submitted for three months, still under review, sent two emails to inquire, but still no response, I really don't understand what's going on
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-09-11 18:44:30 評論於
It has been 40 days since submission, and the status is still "Manuscripts sent to editors," so it is indeed not very fast
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-10-23 16:28:40 評論於
Good pitching is when your ERA is low
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Wspolczesna Onkologia-Contemporary Oncology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*